| Literature DB >> 29386048 |
Savino Spadaro1, Tommaso Mauri2, Stephan H Böhm3, Gaetano Scaramuzzo4, Cecilia Turrini4, Andreas D Waldmann5, Riccardo Ragazzi4, Antonio Pesenti2, Carlo Alberto Volta4.
Abstract
BACKGROUND: Assessing alveolar recruitment at different positive end-expiratory pressure (PEEP) levels is a major clinical and research interest because protective ventilation implies opening the lung without inducing overdistention. The pressure-volume (P-V) curve is a validated method of assessing recruitment but reflects global characteristics, and changes at the regional level may remain undetected. The aim of the present study was to compare, in intubated patients with acute hypoxemic respiratory failure (AHRF) and acute respiratory distress syndrome (ARDS), lung recruitment measured by P-V curve analysis, with dynamic changes in poorly ventilated units of the dorsal lung (dependent silent spaces [DSSs]) assessed by electrical impedance tomography (EIT). We hypothesized that DSSs might represent a dynamic bedside measure of recruitment.Entities:
Keywords: Acute respiratory distress syndrome; Acute respiratory failure; Electrical impedance tomography; Personalized medicine; Positive end-expiratory pressure; Pressure-volume curve
Mesh:
Year: 2018 PMID: 29386048 PMCID: PMC5793388 DOI: 10.1186/s13054-017-1931-7
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Patients’ main characteristics
| Patient | Sex | Age (years) | BMI | SAPS II score (at ICU admission) | SOFA score (on day of study) | Etiology of acute respiratory failure | Days of intubation before study | ARDS (yes or no) | PaO2/FiO2 (mmHg)a | PEEP (cmH2O)a | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 79 | 26 | 33 | 8 | Thoracic trauma | 7 | Yes | 160 | 8 | Nonsurvivor |
| 2 | M | 90 | 29 | 46 | 7 | Sepsis | 1 | Yes | 205 | 10 | Survivor |
| 3 | M | 71 | 29 | 30 | 10 | Postoperative respiratory failure | 2 | No | 230 | 7 | Survivor |
| 4 | F | 80 | 35 | 22 | 9 | Postoperative respiratory failure | 5 | Yes | 263 | 8 | Survivor |
| 5 | M | 69 | 33 | 30 | 4 | Postoperative respiratory failure | 2 | No | 168 | 8 | Survivor |
| 6 | M | 66 | 24 | 40 | 6 | Sepsis | 1 | No | 294 | 6 | Survivor |
| 7 | F | 85 | 19 | 38 | 5 | Septic shock | 1 | No | 273 | 7 | Survivor |
| 8 | F | 80 | 33 | 63 | 10 | Sepsis in hemorrhagic shock | 4 | Yes | 256 | 10 | Survivor |
| 9 | F | 76 | 24 | 33 | 8 | Sepsis | 2 | No | 258 | 7 | Nonsurvivor |
| 10 | F | 75 | 22 | 35 | 5 | Postoperative respiratory failure | 1 | No | 239 | 6 | Survivor |
| 11 | F | 72 | 26 | 38 | 10 | Pneumonia | 6 | No | 175 | 6 | Survivor |
| 12 | F | 78 | 35 | 38 | 11 | Pneumonia | 4 | No | 141 | 6 | Survivor |
| 13 | M | 71 | 34 | 30 | 9 | Pancreatitis | 2 | Yes | 98 | 12 | Survivor |
| 14 | M | 60 | 25 | 29 | 3 | Sepsis | 9 | No | 290 | 6 | Survivor |
| Mean ± SD | 7 M/7 F | 75 ± 8 | 28 ± 5 | 36 ± 10 | 7 ± 2 | 4 ± 5 | 5 Yes/9 no | 217 ± 62 | 7 ± 2 | 2 Nonsurvivors/12 survivors |
Abbreviations: BMI Body mass index, SAPS II Simplified Acute Physiology Score II, ICU Intensive care unit, SOFA Sequential Organ Failure Assessment, ARDS Acute respiratory distress syndrome, PaO/FiO Ratio of partial pressure of oxygen in arterial blood to fraction of inspired oxygen, PEEP Positive end-expiratory pressure
aBefore starting the protocol (clinical)
Lung mechanics, gas exchange, and hemodynamics data
| Variable | PEEP 5 incremental phase | PEEP 10 incremental phase | PEEP 15 | PEEP 10 decremental phase | PEEP 5 decremental phase | Friedman test |
|---|---|---|---|---|---|---|
| VT, ml/kg IBW | 7.4 [7.0–7.8] | 7.5 [7.2–7.8] | 7.6 [7.4–7.8] | 7.6 [7.4–7.8] | 7.6 [7.4–7.8] | 0.171 |
| RR, breaths/minute | 15 [14–16] | 16 [15–18] | 16 [14–18] | 16 [14–18] | 15 [14–18] | 0.275 |
| MV, L/minute | 6.4 [5.8–6.6] | 6.9 [6.4–7.7] | 6.8 [6.5–8.0] | 6.8 [6.5–8.4] | 6.8 [6.4–7.8] | 0.222 |
| Ppeak, cmH2O | 21 [19–28] | 28 [26–30]a | 34 [32–35]a,b | 27 [25–30]a,c | 23 [21–28]b,c,d | <0.001 |
| Pplat, cmH2O | 15 [14–19] | 21 [20–23]a | 26 [25–27]a,b | 20 [18–22]a,b,c | 15 [13–20]b,c,d | < 0.001 |
| Driving pressure, cmH2O | 10 [10–15] | 11 [10–13] | 12 [10–12] | 10 [8–12] | 10 [8–15] | 0.100 |
| Crs, ml/cmH2O | 39 [32–47] | 38 [34–44] | 38 [34–43] | 43 [35–57] | 45 [30–52] | 0.100 |
| PaCO2, mmHg | 53.8 [49.1–59.0] | 53.3 [49.2–58.0] | 54.0 [50.4–59.7] | 52.2 [47.1–56.1] | 51.8 [44.7–57.5] | 0.246 |
| PaO2/FiO2, mmHg | 233 [159–286] | 234 [163–279] | 255 [178–292] | 253 [203–320] | 246 [172–304] | 0.611 |
| pH | 7.33 [7.30–7.39] | 7.34 [7.30–7.41] | 7.32 [7.29–7.40] | 7.34 [7.29–7.38] | 7.34 [7.31–7.39] | 0.170 |
| MAP, mmHg | 70 [66–85] | 76 [67–83] | 71 [64–76] | 74 [66–80] | 78 [70–82] | 0.490 |
| HR, beats/minute | 76 [72–86] | 76 [68–84]a | 72 [67–84]a | 73 [64–83]a | 77 [63–85] | 0.021 |
Abbreviations: PEEP Positive end-expiratory pressure, RM Recruitment maneuver, V Tidal volume, IBW Ideal body weight, RR Respiratory rate, MV Minute ventilation, Ppeak Peak airway pressure, Pplat Plateau airway pressure, Crs Respiratory system compliance, PaCO Partial pressure of carbon dioxide in arterial blood, PaO/FiO Ratio of partial pressure of oxygen in arterial blood to fraction of inspired oxygen, MAP Mean arterial pressure, HR Heart rate
Data are expressed as median [IQR]
Wilcoxon post hoc test analysis for couples: aStatistically significant difference from PEEP 5 incremental phase; bStatistically significant difference from PEEP 10 incremental phase; cStatistically significant difference from PEEP 15; dStatistically significant difference from PEEP 10 decremental phase
Electrical impedance tomography and pressure-volume curve data
| Variable | PEEP 5 incremental phase | PEEP 10 incremental phase | PEEP 15 | PEEP 10 decremental phase | PEEP 5 decremental phase | Friedman test |
|---|---|---|---|---|---|---|
| Nondependent silent spaces, % | 0.4 [0–3.3] | 1.3 [0–3.9] | 1.4 [0.4–4.3] | 1.7 [0.5–3.0] | 0.7 [0.1–2.2] | 0.109 |
| Dependent silent spaces, % | 16.3 [11.7–17.9] | 12.3 [9.2–15.2]a | 8.7 [6.2–11.1]a,b | 10.4 [8.0–12.7]a,c | 13.6 [9.1–16.2]a,c,d | < 0.001 |
| Center of ventilation ventral-dorsal, % | 41.9 [38.1–48.8] | 46.3 [41.8–50.8]a | 49.4 [46.9–54.8]a,b | 47.7 [44.3–52.3]a,c | 43.2 [40.9–50.9]a,c,d | < 0.001 |
| Regional compliance (ROI 4), ml/cmH2O | 3.09 [1.21–4.95] | 4.32 [2.92–6.03]a | 5.90 [4.63–6.8]a,b | 6.01 [4.53–6.53]a,b | 4.27 [2.64–5.34]c,d | < 0.001 |
| Regional compliance (ROI 3), ml/cmH2O | 10.52 [7.74–12.27] | 12.32 [8.64–14.03]a | 13.12 [10.41–14.96]a,b | 13.10 [10.77–17.35]a,b | 11.25 [9.11–14.5]a,d | < 0.001 |
| Regional compliance (ROI 2), ml/cmH2O | 13.9 [12.24–18.97] | 13.55 [12.82–17.06] | 13.09 [11.07–15.93]b | 14.95 [12.59–19.32]b,c | 14.74 [11.38–20.21] | 0.026 |
| Regional compliance (ROI 1), ml/cmH2O | 10.53 [7.51–13.27] | 7.89 [5.93–9.73] | 6.15 [4.63–8.15]a,b | 7.68[6.95–10.96]c | 10.98 [6.26–12.58]c | < 0.001 |
| Tidal distribution index | 1.9 [1.4–2.9] | 1.3 [0.8–1.7]a | 1.0 [0.7–1.2]a,b | 1.3 [1.1–1.7]a,c | 1.8 [1.4–2.2]a,c | < 0.001 |
| Regional compliance dependent lung, ml/cmH2O | 11.9 [10.4–16.7] | 17.7 [12.3–19.2]a | 19.1 [14.2–21.3]a,b | 18.9 [15.7–22.8]a,b | 16.0 [12.3–19.8]a,d | < 0.001 |
| Regional compliance nondependent lung, ml/cmH2O | 25.3 [21.3–30.4] | 22.7 [19.5–25.8] | 20.0 [16.6–22.8]b | 24.3 [18.7–28.5]c | 26.4 [17.5–30.7] | < 0.001 |
| ∆EELV, ml | 170 [132–242] | 495 [411–565]a | 800 [638–943]a,b | 435 [336–574]a,c | 190 [133–262]b,c,d | < 0.001 |
| ∆EELI, ml | 170 [105–260] | 559 [404–716]a | 1190 [903–1378]a,b | 777 [500–930] a,b,c | 270 [191–410]a,b,c,d | < 0.001 |
| Recruitment | Baseline | 87.60 [32.20–119.00] | 114.50 [71.50–171.00] | −82.20 [−164.70 to 3.00] | −101.20 [−158.50 to −28.00] | |
| Recruitment | Baseline | 1.32 [0.66–2.18] | 2.09 [1.05–3.22] | −1.61 [−3.26 to 0.04] | −1.65 [−2.22 to −0.59] |
Abbreviations: PEEP Positive end-expiratory pressure, RM Recruitment maneuver, ROI Region of interest, ∆EELV Change in end-expiratory lung volume, ∆EELI Change in end-expiratory lung impedance, P-V Pressure-volume, IBW Ideal body weight
Data are expressed as median [IQR]
Wilcoxon post-hoc analysis for couples: aStatistically significant difference from PEEP 5 incremental phase; bStatistically significant difference from PEEP 10 incremental phase; cStatistically significant difference from PEEP 15; dStatistically significant difference from PEEP 10 decremental phase
Fig. 1Regional impedance map and “silent spaces” values during the different study phases in a representative patient. The impedance change maps (ΔZ) during the tidal breath are shown in the upper row for each step of the protocol; in the lower row, the corresponding level of silent spaces and center of ventilation are reported. Upon incrementally increasing positive end-expiratory pressure (PEEP), the percentage of dependent silent spaces decreased, whereas the opposite was true for decreasing PEEP levels
Fig. 2Correlation between dependent silent spaces and recruited lung volume assessed by pressure-volume (P-V) curve. The recruited volume determined by the shift in lung volumes between the P-V curves performed at different levels of positive end-expiratory pressure (PEEP) correlated inversely with the percentage change in dependent silent spaces. IBW Ideal body weight